Thompson Siegel & Walmsley LLC Grows Stock Position in Gilead Sciences, Inc. (NASDAQ:GILD)
Thompson Siegel & Walmsley LLC lifted its holdings in shares of Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 65.2% during the third quarter, according to its most recent disclosure with the SEC. The fund owned 111,305 shares of the biopharmaceutical company’s stock after acquiring an additional 43,921 shares during the period. Thompson Siegel & […]
More Stories
Trip.com Group (NASDAQ:TCOM) Given New $80.00 Price Target at Benchmark
Trip.com Group (NASDAQ:TCOM – Free Report) had its price target boosted by Benchmark from $72.00 to $80.00 in a research...
BMO Capital Markets Lowers Ascot Resources (TSE:AOT) Price Target to C$0.75
Ascot Resources (TSE:AOT – Free Report) had its price objective trimmed by BMO Capital Markets from C$1.25 to C$0.75 in...
Trevena (NASDAQ:TRVN) Coverage Initiated by Analysts at StockNews.com
StockNews.com initiated coverage on shares of Trevena (NASDAQ:TRVN – Free Report) in a research report report published on Tuesday. The...
Aclaris Therapeutics (NASDAQ:ACRS) Upgraded by BTIG Research to Buy Rating
BTIG Research upgraded shares of Aclaris Therapeutics (NASDAQ:ACRS – Free Report) from a neutral rating to a buy rating in...
Siemens Aktiengesellschaft (OTCMKTS:SIEGY) Rating Lowered to Neutral at Bank of America
Bank of America cut shares of Siemens Aktiengesellschaft (OTCMKTS:SIEGY – Free Report) from a buy rating to a neutral rating...
Origin Agritech (NASDAQ:SEED) Earns Hold Rating from Analysts at StockNews.com
StockNews.com began coverage on shares of Origin Agritech (NASDAQ:SEED – Free Report) in a research note published on Tuesday. The...